EPCAM and malignant colon neoplasm: Another explanation is that the group of determinant CTCs had not been precisely identified, exemplified by the fact that only vimentin-positive CTCs were related to patients’ outcomes rather than EpCAM-positive CTCs in colon cancers (22).